Pharmaceutical firm Ipca Laboratories on Wednesday announced the acquisition of 80 per cent stake in US Bayshore Pharmaceuticals LLC by its subsidiary for $10.286 million (approx Rs 75.4 crore).

In a regulatory filing, Ipca Laboratories said the endeavour will help the company to commercialise its registered generics drug products in the US market through this entity.

 The companys wholly-owned subsidiary, Ipca Pharmaceuticals Inc., USA, has acquired, on October 2, 2018, 80 per cent share capital of Bayshore Pharmaceuticals LLC, a New Jersey limited liability company …for cash $10.286 million, it added.

For its financial year ended December 31, 2017, Bayshore had a total income of $7.05 million.

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.